Mashup Score: 28
TheHillFDA advisers did vote for a narrower use for Americans above the age of 65 or at high risk of severe
See more from Amesh Adalja
In this piece I write about the debate over #COVID19 vaccine boosters. I think the FDA advisors were right in how they handled this decision and stuck to the clinical evidence https://t.co/1kG5JCAe4B - view on twitter